The Effect of Methylphenidate Treatment on Oxidative Stress Levels in Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD)

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

June 26, 2024

Primary Completion Date

January 6, 2025

Study Completion Date

January 6, 2025

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
OTHER

This is not an interventional study. Patients who are planned to start methylphenidate treatment have been invited to participate in the study.

This is not an interventional study. Patients diagnosed with Attention Deficit Hyperactivity Disorder (ADHD), for whom methylphenidate treatment is planned, have been invited to participate in the study. The patients have been enrolled in follow-up, and our contact information has been provided to them. As part of routine care, patients have been called in once a month. Necessary dosage adjustments have been made in accordance with medical guidelines, without any intervention for the study. Patients with complaints or those who needed to be seen earlier have been seen in between. As a result, the patients were followed for a total of 3 months for this study. Serum samples for oxidative stress markers were collected at baseline (before treatment started) and at the 3rd month (after treatment began).

Trial Locations (1)

34147

Bakırköy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Saglik Bilimleri Universitesi

OTHER

NCT06844812 - The Effect of Methylphenidate Treatment on Oxidative Stress Levels in Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter